CGBIO launches ‘MEDICLORE’, an anti-adhesion agent in Indonesia

• DATE 2022-06-07
• VIEWSViews : 3,691 views

CGBIO cooperates with US WFIRM to conduct bone and cartilage regeneration research using 3D printing

• DATE 2022-05-12
• VIEWSViews : 1,692 views

CGBIO Reached 94.6 Billion Won in Sales in 2021 Sales Up 133% Over 5 Years, Rapid Operating Profits Increase by 471%

• DATE 2022-04-13
• VIEWSViews : 2,323 views

CGbio and Kerunxi Medical of China sign 10 billion KRW contract for export of Bongros dental bone graft material

• DATE 2022-03-23
• VIEWSViews : 3,154 views

CGBIO signed an export contract worth KRW 100 billion for “BONGROS”, a bone replacement material with Shanghai Sanyou Medical

• DATE 2022-03-04
• VIEWSViews : 3,237 views

CGBIO established a corporation in Indonesia and entered the Southeast Asian aesthetic surgery market

• DATE 2022-03-04
• VIEWSViews : 3,300 views

Renewed Version of a Wound Therapeutic Instrument exploiting negative pressure, the ‘CURAVAC’, attained an Approval in China

• DATE 2022-03-02
• VIEWSViews : 2,224 views

BELUNA, the Bread Massaging Instrument of CGBIO, attained the Certification of Medical Instrument… Propagation of the ‘Solution for Natural Breast’ is expectedly promoted…

• DATE 2022-03-02
• VIEWSViews : 1,834 views

CGBIO obtains approval for next-generation ceramic cage ‘NOVOMAX Fusion’ in Australia

• DATE 2021-11-11
• VIEWSViews : 1,620 views

CGBIO gets green light in Mexico for BMP-2 bone graft NOVOSIS

• DATE 2021-09-29
• VIEWSViews : 2,423 views